The dupilumab group had significant differences vs the other groups, with increased values for FEF 25-75% at months 6 and 12, and for FEF 75% at month 12. Four biologics — omalizumab, mepolizumab, ...
When an orchestrator call an activity with no parameters data, the warning DURABLE2001 is raised with the following message: CallActivityAsync is passing the incorrect type 'none' instead of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback